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Deproteinized bone with VEGF gene transfer to facili-
tate the repair of early avascular necrosis of femoral
head of rabbit
CAO Kai 曹凯*, HUANG Wei 黄伟, AN Hong 安洪, JIANG Dian-ming 蒋电明, SHU Yong 舒勇 and HAN Zhi-min 韩智敏
Objective:    To explore a new method for early avascular
necrosis of femoral head (AVNFH) therapy.
Methods:    Sixty-nine AVNFH New Zealand adult rab-
bits were randomly divided into three groups with equal
number. In Group A, deproteinized bone (DPB) that absorbed
with recombinant plasmid pcDNA3.1-hVEGF165 was im-
planted into the drilled tunnel of necrotic femoral head. In
Group B, only DPB was implanted. In Group C, only tunnel
was drilled without DPB or plasmid implanted. Femoral head
specimens were obtained at postoperative 1, 2, 4, 8, 16
weeks. The expression of VEGF165 and collagen I was de-
tected by immunohistochemistry. Bone formation was de-
tected generally by X-ray. Angiogenesis and the repair of
the femoral head were observed histologically.
Results:    The expression of VEGF 165 could be de-
tected 2 weeks after implantation in Group A, but it was not
observed in other groups. The result of collagen I expres-
sion had a significantly difference 2, 4 and 8 weeks after
operation in Group A from those in other groups (P<0.01).
X-ray results indicated that there was more bone formation
in Group A than in other groups. The regenerated capillary
vessels staining result of necrotic femoral head in Group A
was significantly different from those in other groups at
postoperative 2 and 4 weeks (P<0.01).
Conclusions:  Transfection of hVEGF165 gene enhances
local angiogenesis and DPB-VEGF compound improves the
repair of necrotic femoral head. Deproteinized bone grafting
with VEGF gene transfer provides a potential method for
the treatment of osteonecrosis.
Key words:    Vascular endothelial growth factor; Gene
therapy; Femoral head necrosis
Avascular necrosis of femoral head (AVNFH) isan intractable disease that usually leads to de-struction of the hip joint and increases muscu-
loskeletal morbidity in young and middle-aged patients
who receive total hip replacement ultimately, but mean-
while have to confront long-term complications or
revision. 1 Thus, it is significant to delay or decrease
the need of total hip replacement by a method that could
enhance the repair of injured femoral head before
collapse. Current therapies that preserve the femoral
head in early stage of AVNFH, including non-operative
treatments, core decompression and other methods,
are not satisfactory. There is as yet no reliable therapy
for early AVNFH.2 Here, we implanted DPB-VEGF com-
pound into the necrotic femoral head and tried to in-
duce angiogenesis and promote the repair of necrotic
femoral head.
METHODS
Amplification and purification of pcDNA3.1-
hVEGF165
VEGF eukaryotic expression plasmid pcDNA3.1-
hVEGF165 containing the full length of hVEGF165 cDNA
was provided by orthopedic laboratory of the First Affili-
ated Hospital, Chongqing University of Medical
Sciences, Chongqing, China. The plasmid was firstly
purified according to the method of precipitation with
polyethylene glycol after amplification, then confirmed
by digestion with restriction endonuclease EcoR I and
Xba I.
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Preparation of DPB-VEGF compound
Allogenous rabbit cancellous bone was processed
into DPB by being deproteinized with hydrogen perox-
ide and defatted with ethoxyethane. 3 After that, DPBs
were shaped into small sticks at the diameter of 3.0
mm and sterilized by epoxyethane. Then, each DPB
was absorbed with a dose of 1000 µg pcDNA3.1-
hVEGF165 plasmid and freeze-dried under sterile con-
dition for implantation.
Establishment of animal models and implantation
of DPB-VEGF compound
AVNFH models were screened and confirmed by
magnetic resonance imaging (MRI) after injection with
horse serum (PAA, Germany) intravenously and dex-
amethasone sodium phosphate intraperitoneally as
well.4 Sixty-nine AVNFH New Zealand rabbits were ran-
domly divided into three groups with equal number. In
Group A, a 3.0 mm diameter tunnel was drilled from the
lateral side of proximal end of bilateral femur to the femo-
ral head along the axis of femoral neck. After that, the
DPB-VEGF compound was implanted into the tunnel.
In Group B, only DPB was implanted into the tunnel. In
Group C, nothing was implanted into the tunnel. Femo-
ral head specimens were obtained at 1, 2, 4, and 8
weeks after implantation.
Immunohistochemical analysis
Specimens at postoperative 1, 2, 4, and 8 weeks
were dehydrated, embedded and sectioned. Slices were
dewatered and incubated in 3% hydrogen peroxide to
block the endogenous peroxidase activity. After that,
slices were incubated with monoclonal mouse anti-hu-
man VEGF antibody in Group A (Santa Cruz
Biotechnology, Inc. USA), polyclonal rabbit anti-rabbit
collagen I antibody in Group B (Boster, Wuhan, China),
then incubated with alkaline phosphatase-conjugated
horse anti-mouse secondary antibody (Zhongshan Bio-
technology Co., Ltd. China) and horseradish peroxidase
(HRP)-conjugated goat anti-rabbit secondary antibody
(Boster,Wuhan, China) respectively. The signal was
detected by a detective system (Zhongshan Biotech-
nology Co., Ltd. China). PBS replaced VEGF or col-
lagen I antibody as negative control. Five sites of each
slice were selected randomly. The image-analysis sys-
tem detected the positive staining and analyzed the
ratio of integrated optical density to the statistical re-
gion (IOD/µm2).
Observing bone formation on X-ray image
All rabbits received hip X-ray test at postoperative
2, 4, 8 and 16 weeks for assessment of new bone
callus.
Capillary vessels infusion
After anesthesia, make an incision and expose
abdomial aorta and inferior vena cava. Intubate abdomial
aorta, inject 12500 U heparin and infuse with 500 ml
saline. Exanguinate inferior vena cava untill the color of
nail bed and muscle in low extremities turned into white
and the discharged liquid became clear. Then infuse
Chinese ink untill the color of nail bed and muscle of
low extremities turned into black. Ligate abdomial aorta
and inferior vena cava, take the femoral heads and store
them at 4°C for 24 hours. Specimens at postoperative
1, 2, 4, and 8 weeks were fixed,decalcified and sec-
tioned into transparent slices. Capillary vessels were
observed and analyzed with image-analysis system
according to the same method mentioned above.
Histomorphometric analysis
Specimens at postoperative 1, 2, 4, 8 and 16 weeks
were sectioned into slices, which were then stained
with hematoxylin and eosin for histological observation.
Statistical analysis
With SAS 8.2 software, data were analyzed by t
test and P<0.05 was considered as statistically signifi-
cant difference. The results were denoted by the value
of t and P.
RESULTS
Analysis of pcDNA3.1-hVEGF165 after purification
and animal model construction
A  pcDNA3.1 fragment (5.4 kb) and a hVEGF165
fragment (about 600 bp) were present after vector di-
gestion with EcoR I and Xba I (Fig. 1), which indicated
that the amplified and purificated plasmid was pcDNA
3.1-hVEGF165. MRI revealed that all screened-out New
Zealand adult rabbits took on high inhomogeneous sig-
nal in the femoral head (Fig. 2), which indicated that
animal models were constructed successfully.
The results of X-ray test
X-ray image of femoral head indicated that primary
bone formed in the tunnel, with transparent area around
the implant 2 weeks after operation in Group A. Trans-
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parent area became vague with uniform density and
abundant new bone formed in the tunnel 4 weeks after
operation in Group A. The amount of new bone in Group
B was less than that in Group A 4 and 8 weeks after
operation. No obvious new bone formed in the drilled
tunnel 4 and 8 weeks after operation in Group C (Fig.3).
The bone density of the implant region was similar to
that of normal surrounding bone at postoperative 16
weeks in Groups A and B. The bone density remained
low at postoperative 16 weeks in Group C.
hVEGF165 and collagen  I immunohistochemical
analysis
Marrow cells in the femoral head and osteoblasts
attaching on the bone trabeculae transfected with
hVEGF 165 gene were dyed blue 1 and 2 weeks after
implantation (Fig.4). This confirmed that pcDNA3.1-
hVEGF165 plasmid was transfected successfully into
these cells in Group A. However, VEGF165 expression
could not be detected in the femoral head 1 and 2 weeks
after operation in other groups.
Collagen I in the femoral head was dyed brown at post-
operative 2, 4 and 8 weeks (Fig.5). The image analysis
results revealed IOD/µm2 of collagen I was distinctly higher
in Group A than other groups at postoperative 2, 4 and 8
weeks (P<0.01, Table.1).
New capillary vessels formation after operation
The capillary vessels formed in the repair region 2
and 4 weeks after operation in Group A (Fig.6). The IOD/
µm2 of the positive capillary staining were significantly
different between Group A and other groups (P<0.01),
but no significant difference was observed among groups
1 and 8 weeks after operation (P>0.05, Table 2).
New bone formation after implantation
One week after operation, the tunnel was mainly suf-
fused with erythrocytes and marrow cells in all groups.
However, a small amount of fibroid tissues were observed
around DPB in Group A.
Two weeks after operation in Group A, obvious osteo-
genesis was observed. Many collagen fibers and new bones
attached to DPB and necrotic bone. Proliferative mesenchy-
mal cells and fibroblasts presented in tunnel and marrow
cavity. Less collagen fibers and less new bone formation
could be observed around DPB and necrotic bone in Group
B. Much less collagen fiber generated in tunnel of Group C.
Four weeks after implantation, a great amount of
new trabeculae presented in tunnel as well as on the
surface of DPB and necrotic trabeculae in Group A. In
Group B, collagen fiber and primary osteoid tissue were
found from the border of necrotic bone and DPB. Abun-
dant collagen tissue, fibroblasts, proliferative mesenchy-
mal cells presented in tunnel of Group C.
Table 1. The result of image-analysis of immunohis-
tochemical staining of collagen I (IOD/µm2, χ ± s)
Groups         2 weeks              4 weeks                8 weeks
0.29 ± 0.11         0.55 ± 0.13            0.67 ± 0.10
0.12 ± 0.04          0.33 ± 0.09            0.45 ± 0.12
0.07 ± 0.04          0.23 ± 0.10            0.31 ± 0.08
5.625, 0.0001    5.389, 0.0001       5.455, 0.0001
7.280, 0.0001    7.556, 0.0001     10.887, 0.0001
3.423, 0.0006    2.879, 0.0040       3.760, 0.0002
A
B
C
t1, P1
t2, P2
t3, P3
t1, P1: Compared between Groups A and B; t2, P2: Between Groups
A and C; t3, P3: Between Groups B and C.
Table 2. The result of image-analysis of capillary vessels
(IOD/µm2, χ ± s)
Groups
 A
 B
 C
 t1, P1
 t2, P2
 t3, P3
1 week
0.07±0.04
0.05±0.04
0.06±0.04
1.369, 0.1709
0.685, 0.4936
0.685, 0.4936
2 weeks
0.33±0.10
0.17±0.09
0.18±0.08
4.606, 0.0001
4.536, 0.0001
0.321, 0.3216
4 weeks
0.57±0.16
0.35±0.08
0.22±0.09
4.763, 0.0001
7.384, 0.0001
4.181, 0.0001
8 weeks
0.56±0.11
0.48±0.12
0.48±0.18
1.903, 0.0570
1.469, 0.1419
0,        1
t1, P1: Compared between Groups A and B; t2, P2: Between Groups
A and C; t3, P3: Between Groups B and C.
Fig.1. Eelectrophoretic identification after digestion with restric-
tion endonuclease.1-2:digested with restriction endonuclease EcoR
I and Xba I; 3: Marker (λDNA/EcoR I +Hind III). Fig.2. MRI image
of rabbit. A high inhomogeneous signal presented under Stir se-
quence in the femoral head.
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Eight weeks after operation in Group A, mature re-
generative trabeculae formed, in which some substi-
tuted DPB and necrotic trabeculae. Meanwhile, DPB
had been absorbed partly. In Group B, new trabeculae
substituted DPB and necrotic trabeculae in the tunnel.
Simultaneously, DPB was initiatively absorbed. Mar-
row cavity is filled with new osteoid tissue and collagen
tissue in Group C (Figs.7-9).
Sixteen weeks after operation, a variety of normal
marrow cells and mature trabeculae presented in bone
marrow cavity of femoral head, accompanied with rem-
nants of DPB, in Groups A and B. In Group C, obvious
osteogenesis processed, without mature regenerated
trabeculae and normal intra-marrow structure.
Fig.3. A: X-ray of femoral head 4 weeks after operation in Group A. Transparent area became vague with uniform density and abundant
new bone formed in tunnel. B: X-ray of femoral head 8 weeks after operation in Group A. More new bone formed and transparent area
disappeared. C: X-ray of femoral head 4 weeks after operation in Group B. A small amount of new bone formed. D: X-ray of femoral head
8 weeks after operation in Group B. New bone formed, which was less than Group A. E: X-ray of femoral head 4 weeks after operation
in Group C. No new bone formed in the drilled tunnel. F: X-ray of femoral head 8 weeks after operation in Group C. No obvious new bone
formed in the drilled tunnel.
Fig.4.  Immunohistochemical analysis of VEGF 2 weeks after operation in Group A. A large number of blue-stain osteoblasts attached to
new trabeculae (×100). Fig.5.  Immunohistochemical analysis of collagen I 4 weeks after operation in Group A. Brown-dyed collagen I
creeped onto new trabeculae and DPB (×100).  Fig.6. Chinese ink infusion analysis of capillary vessels in femoral head 2 weeks after
operation. A number of capillary vessels formed in the repair region (×200). Fig.7. Femoral head in Group A 8 weeks after operation.
Abundant mature trabeculae formed, part of which substituted DPB and necrotic trabeculae. DPB had been eliminated partly (HE; ×40).
Fig.8. Femoral head in Group B 8 weeks after operation. New creeping trabeculae substituted DPB and necrotic trabeculae. DPB was
initiatively absorbed (HE; ×40). Fig.9. Femoral head in Group C 8 weeks after operation. Marrow cavity was filled with new osteoid tissue
and collagen tissue (HE; ×40).
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 DISCUSSION
The spontaneous repair of AVNFH is characterized
by necrotic bone resorption and fibrovascular tissue
invasion. Destructive resorption without constantly ef-
fective bone formation contributes to the collapse of
the articular surface and mechanical instability, which
accelerates the formation of AVNFH with secondary joint
destructions.5 The key of therapy is to transform the
pathological mechanism that the spontaneous angio-
genesis and osteogenesis initiate slowly, but resorp-
tion of necrotic trabeculae develops rapidly. So, it is
very important to promote the proliferation of capillaries
and formation of new bone in the early treatment of AV
NFH.
DPB possesses natural micropore network system.
It is beneficial for mesenchymal cells immigration and
capillary vessels invasion, which is the basis of
osteogenesis. DPB processed with hydrogen peroxide
and ether has better mechanical strength as compared
with Oswestry bone, Kiel bone or DPB prepared with
alcohol, and is more appropriate to be used as bone
graft material. 6,7 Furthermore, as a kind of biological
material, allogenous DPB has the similar structure to
host bone. DPB not only promote osteoblastic
differentiation, matrix synthesis and bone formation, but
also can be eliminated ultimately by host osteoclasts. 8, 9
We also found DPB was substituted extensively by
many new creeping bones in this experiment.
Meanwhile, DPB was degraded and resorbed gradually
(Fig.7). Experiments reveal that DPB has good cellular
compatibil ity and histocompatibi lity.10-12 In this
experiment, a small number of lymphocytes and in-
flammatory cells presented in early period of implanta-
tion but disappeared later. All the operative incisions
healed without red swelling of the skin or suppuration.
Our previous clinical results indicated that DPB is as
safe as autogenous bone. 13 So DPB is a satisfactory
bone graft material.
The transformation of DPB into activated allograft
depends on its revascularization and mesenchymal
cells immigration.14 Because of VEGF’s specific role in
vasculogenesis, it has been used for therapeutic an-
giogenesis of cardiac and lower limb ischemia.15-17 So
we are enlightend and try to apply VEGF to induce
revascularization of AVNFH. However, VEGF protein is
easy to be diluted due to its short half life. Effective
delivery of VEGF protein is the premise of realizing its
function. VEGF gene therapy offers a novel approach
to overcome the disadvantage of VEGF protein therapy.18
We applied VEGF gene transfer to induce angiogen-
esis in necrotic femoral head in this experiment, which
indicated that there were more new capillary vessels
formed in DPB-VEGF group 2 and 4 weeks after im-
plantation (P<0.01).
Human VEGF mRNA was expressed in the trans-
fected ischemic muscles 14 days after gene transfer
and transfection efficiency was six-fold higher in is-
chemic muscles than in nonischemic control muscles.19
Yang’s experiment20 demonstrated that hVEGF165
mRNA was detected in the necrotic femoral head 2
weeks after VEGF gene transfer. In Yang’s research,
with collagen as plasmid carrier, compared with DPB,
there was lack of mechanical features for grafting. In
this experiment, immunohistochemical test revealed
that VEGF165 was also expressed for 2 weeks in the
necrotic marrow cavity of rabbit femoral head, which is
enough to induce angiogenesis.
In conclusion, hVEGF165 gene transfer enhances
local angiogenesis in early stage and DPB-VEGF com-
pound promotes bone formation and facilitates the re-
pair of early AVNFH. DPB grafting with VEGF gene
transfer provides a potential method for the treatment
of osteonecrosis.
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